BMA(BMA)
BMA
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $6.08T | $7.15T | $9.22T | $13.10T | $13.65T |
| Low | $4.60T | $5.41T | $6.98T | $9.91T | $10.33T |
| High | $7.17T | $8.44T | $10.88T | $15.45T | $16.11T |
| EBITDA Avg | $726.38B | $854.61B | $1.10T | $1.57T | $1.63T |
| Low | $549.61B | $646.63B | $833.92B | $1.18T | $1.23T |
| High | $856.89B | $1.01T | $1.30T | $1.85T | $1.92T |
| EBIT Avg | $623.46B | $733.52B | $945.98B | $1.34T | $1.40T |
| Low | $471.74B | $555.01B | $715.77B | $1.02T | $1.06T |
| High | $735.48B | $865.32B | $1.12T | $1.59T | $1.65T |
| Net Income Avg | $631.05B | $1.08T | $1.39T | — | — |
| Low | $578.21B | $958.48B | $987.78B | — | — |
| High | $683.89B | $1.20T | $1.78T | — | — |
| EPS Avg | $9878.64 | $16863.76 | $22597.20 | — | — |
| Low | $9042.76 | $14990.01 | $15448.21 | — | — |
| High | $10695.53 | $18737.51 | $27875.49 | — | — |
| Analysts (Rev / EPS) | 6 / 2 | 6 / 2 | 6 / 1 | 5 / — | 3 / — |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $1.44T | $1.52T | $1.69T | $1.72T | $1.66T | $1.73T |
| Low | $1.30T | $1.37T | $1.53T | $1.55T | $1.50T | $1.57T |
| High | $1.55T | $1.63T | $1.82T | $1.84T | $1.78T | $1.86T |
| EBITDA Avg | $172.17B | $181.38B | $202.20B | $205.18B | $197.96B | $207.13B |
| Low | $155.67B | $164.00B | $182.82B | $185.52B | $178.99B | $187.28B |
| High | $184.75B | $194.64B | $216.98B | $220.18B | $212.43B | $222.28B |
| EBIT Avg | $147.77B | $155.68B | $173.55B | $176.11B | $169.91B | $177.78B |
| Low | $133.61B | $140.76B | $156.92B | $159.23B | $153.63B | $160.74B |
| High | $158.58B | $167.06B | $186.24B | $188.99B | $182.33B | $190.78B |
| Net Income Avg | $159.66B | $161.07B | $212.08B | $251.83B | $239.47B | $268.93B |
| Low | $139.77B | $141.00B | $185.65B | $220.45B | $209.63B | $235.42B |
| High | $174.84B | $176.38B | $232.23B | $275.76B | $262.23B | $294.49B |
| EPS Avg | $2497.09 | $2519.11 | $3316.85 | $3938.56 | $3745.35 | $4206.09 |
| Low | $2185.95 | $2205.23 | $2903.56 | $3447.81 | $3278.67 | $3682.00 |
| High | $2734.41 | $2758.53 | $3632.08 | $4312.88 | $4101.30 | $4605.83 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |